Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Canaan is an early-stage venture capital firm founded in 1987 and headquartered in Stamford, Connecticut. The firm has additional offices in New York and Menlo Park, California. With over 35 years of experience, Canaan has established itself as a leader in the venture capital space, particularly in the healthcare and technology sectors.
As of now, Canaan manages a fund size of $650 million and has achieved over 200 exits, including 73 IPOs and 152 M&A transactions. The firm is known for its commitment to supporting visionary entrepreneurs and companies that are poised to make significant impacts in their respective fields. Canaan's extensive experience and diverse portfolio make it a compelling partner for startups seeking to leverage their network and expertise.
Canaan primarily invests in early-stage companies across the technology (60%) and healthcare/bio-pharma (40%) sectors. The firm targets entrepreneurs with visionary concepts and emphasizes a personal approach through a diverse team. Canaan's investment strategy includes seed, Series A, and Series B stages, with check sizes ranging from $2 million to $15 million.
The firm seeks to identify promising early science and partners with knowledgeable investors to shape company strategies. Canaan's investment thesis focuses on transformative ideas that leverage advancements in science and technology to create societal benefits, particularly in the healthcare and technology sectors.
Canaan's notable portfolio includes a variety of companies across different sectors. Some of the key companies are:
These companies reflect Canaan's commitment to investing in transformative ideas within the healthcare and technology sectors.
Deepak Kamra: General Partner / West Coast. Deepak has extensive experience in venture capital and has led numerous successful investments in technology and healthcare.
John Balen: Partner / West Coast. John specializes in early-stage investments and has a strong background in technology startups.
Stephen Bloch: General Partner / East Coast. Stephen has a wealth of experience in venture capital and has been instrumental in Canaan's growth.
Hrach Simonian: General Partner / West Coast. Hrach focuses on healthcare investments and has a deep understanding of the biotech landscape.
Paul Fonteyne: Executive in Residence / East Coast. Paul brings a wealth of operational experience to the firm.
John Pacifico: General Partner, COO + CFO / East Coast. John oversees Canaan's operations and financial strategies.
Nils Lonberg: Executive in Residence / West Coast. Nils has a strong background in biotech and healthcare investments.
Mikael Dolsten: Executive in Residence / East Coast. Mikael has extensive experience in the pharmaceutical industry and provides valuable insights to portfolio companies.
To pitch to Canaan, founders should visit their website at canaan.com or email hello@canaan.com. It is recommended to include a comprehensive deck that outlines the business model, market opportunity, and team. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
On December 1, 2025, Canaan made its latest investment, continuing its active engagement in the venture capital ecosystem. Over the past 12 months, the firm has completed 10 investments, showcasing its commitment to supporting early-stage companies in the healthcare and technology sectors.
Q?
What are Canaan's investment criteria?
Canaan invests in early-stage companies primarily in the healthcare and technology sectors, focusing on seed, Series A, and Series B stages with check sizes ranging from $2 million to $15 million.
Q?
How can startups apply or pitch to Canaan?
Startups can pitch to Canaan through their website at canaan.com or by emailing hello@canaan.com. It is advisable to include a detailed deck outlining the business model, market opportunity, and team.
Q?
What makes Canaan different from other venture capital firms?
Canaan has a strong focus on transformative ideas and a proven track record of over 200 exits, including 73 IPOs. Their extensive experience and diverse portfolio provide valuable insights and resources for entrepreneurs.
Q?
What is Canaan's geographic scope?
Canaan primarily invests in North America, focusing on early-stage companies within the region.
Q?
What kind of post-investment involvement does Canaan have?
Canaan adds value through strategic advice, industry connections, and a commitment to fostering innovation, helping entrepreneurs navigate challenges and achieve growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.